{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:05:41Z","timestamp":1787497541132,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000063","name":"Office of Dietary Supplements","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHS-N-260-2005-00007-C"],"award-info":[{"award-number":["HHS-N-260-2005-00007-C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01-EY-5-0007"],"award-info":[{"award-number":["N01-EY-5-0007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ophtha.2023.09.013","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T09:26:36Z","timestamp":1694942796000},"page":"208-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Critical Dependence on Area in Relationship between ARMS2\/HTRA1 Genotype and Faster Geographic Atrophy Enlargement"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-4042","authenticated-orcid":false,"given":"Elvira","family":"Agr\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cukras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-1772","authenticated-orcid":false,"given":"Tiarnan D.L.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ophtha.2023.09.013_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2023.09.013_bib2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2023.09.013_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.09.013_bib4","series-title":"FDA approves SYFOVRETM (pegcetacoplan injection) as the first and only treatment for geographic atrophy (GA), a leading cause of blindness","year":"2023"},{"issue":"2","key":"10.1016\/j.ophtha.2023.09.013_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2023.09.013_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2023.09.013_bib7","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2023.09.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100057","article-title":"Local complement inhibition for geographic atrophy in age-related macular degeneration: prospects, challenges, and unanswered questions","volume":"1","author":"Keenan","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2023.09.013_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.ophtha.2023.09.013_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration","volume":"137","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2023.09.013_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.oret.2022.08.018","article-title":"Deep learning to predict geographic atrophy area and growth rate from multimodal imaging","volume":"7","author":"Anegondi","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.ophtha.2023.09.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100306","article-title":"Geographic atrophy in age-related macular degeneration: a tale of two stages","volume":"3","author":"Keenan","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2023.09.013_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oret.2022.08.022","article-title":"Treating geographic atrophy\u2014are we ready? A call to image","volume":"7","author":"Guymer","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2023.09.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109092","article-title":"Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials","volume":"220","author":"Yaghy","year":"2022","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ophtha.2023.09.013_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A\u00a0large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ophtha.2023.09.013_bib17","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ophtha.2009.12.012","article-title":"Progression of geographic atrophy and genotype in age-related macular degeneration","volume":"117","author":"Klein","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2023.09.013_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126636","article-title":"Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration","volume":"10","author":"Grassmann","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ophtha.2023.09.013_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007418","article-title":"CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD","volume":"4","author":"Scholl","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ophtha.2023.09.013_bib20","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ophtha.2020.12.030","article-title":"Re: Jaffe et\u00a0al.: C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial (Ophthalmology. 2021;128:576\u2013586)","volume":"128","author":"Keenan","year":"2021","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2023.09.013_bib21","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2023.09.013_bib22","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1167\/iovs.13-11804","article-title":"Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2)","volume":"54","author":"Danis","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2023.09.013_bib23","first-page":"1761","article-title":"Measuring geographic atrophy in advanced age-related macular degeneration","volume":"40","author":"Sunness","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2023.09.013_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2022.03.022","article-title":"Adherence to a Mediterranean diet and geographic atrophy enlargement rate: Age-Related Eye Disease Study 2 report 29","volume":"6","author":"Agron","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ophtha.2023.09.013_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","article-title":"Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26","volume":"131","author":"Feuer","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2023.09.013_bib26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1080\/03610929408831436","article-title":"General class of covariance structures for two or more repeated factors in longitudinal data analysis","volume":"23","author":"Galecki","year":"1994","journal-title":"Commun Stat Theory Methods"},{"issue":"2","key":"10.1016\/j.ophtha.2023.09.013_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.iae.0000248148.56560.b1","article-title":"Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study","volume":"27","author":"Sunness","year":"2007","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ophtha.2023.09.013_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2022.11.026","article-title":"Reticular pseudodrusen status, ARMS2\/HTRA1 genotype, and geographic atrophy enlargement: Age-Related Eye Disease Study 2 report 32","volume":"130","author":"Agron","year":"2023","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ophtha.2023.09.013_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2022.05.021","article-title":"Reticular pseudodrusen: the third macular risk feature for progression to late age-related macular degeneration: Age-Related Eye Disease Study 2 report 30","volume":"129","author":"Agron","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.09.013_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2021.06.017","article-title":"Phase 1 study of the anti-HtrA1 antibody-binding fragment FHTR2163 in geographic atrophy secondary to age-related macular degeneration","volume":"232","author":"Khanani","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2023.09.013_bib32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2023.05.004","article-title":"Progression dynamics of early versus later-stage atrophic lesions in non-neovascular AMD using quantitative OCT biomarker segmentation","volume":"7","author":"Coulibaly","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"11","key":"10.1016\/j.ophtha.2023.09.013_bib33","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related Eye Disease Study 2 report number 11","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"issue":"395","key":"10.1016\/j.ophtha.2023.09.013_bib34","doi-asserted-by":"crossref","first-page":"eaaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.ophtha.2023.09.013_bib35","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","article-title":"Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area","volume":"32","author":"Khanifar","year":"2012","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ophtha.2023.09.013_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1534\/genetics.116.196998","article-title":"Bivariate analysis of age-related macular degeneration progression using genetic risk scores","volume":"206","author":"Ding","year":"2017","journal-title":"Genetics"},{"issue":"7","key":"10.1016\/j.ophtha.2023.09.013_bib37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ophtha.2022.02.026","article-title":"The phenotypic course of age-related macular degeneration for ARMS2\/HTRA1: the EYE-RISK Consortium","volume":"129","author":"Thee","year":"2022","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202300670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202300670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T10:46:12Z","timestamp":1719053172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164202300670X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S016164202300670X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.09.013","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical Dependence on Area in Relationship between ARMS2\/HTRA1 Genotype and Faster Geographic Atrophy Enlargement","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}